Mettler-Toledo International Inc. (NYSE:MTD) Shares Acquired by Crown Oak Advisors LLC

Crown Oak Advisors LLC increased its holdings in Mettler-Toledo International Inc. (NYSE:MTD) by 14.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,644 shares of the medical instruments supplier’s stock after acquiring an additional 702 shares during the quarter. Mettler-Toledo International makes up about 3.6% of Crown Oak Advisors LLC’s holdings, making the stock its 15th biggest position. Crown Oak Advisors LLC’s holdings in Mettler-Toledo International were worth $6,906,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of MTD. Blue Trust Inc. increased its stake in Mettler-Toledo International by 242.9% in the third quarter. Blue Trust Inc. now owns 24 shares of the medical instruments supplier’s stock valued at $34,000 after purchasing an additional 17 shares during the period. Ashton Thomas Securities LLC purchased a new position in shares of Mettler-Toledo International during the third quarter worth about $37,000. Raleigh Capital Management Inc. increased its position in Mettler-Toledo International by 272.7% in the 3rd quarter. Raleigh Capital Management Inc. now owns 41 shares of the medical instruments supplier’s stock valued at $61,000 after acquiring an additional 30 shares during the period. Whittier Trust Co. of Nevada Inc. raised its stake in Mettler-Toledo International by 60.0% during the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 48 shares of the medical instruments supplier’s stock valued at $72,000 after acquiring an additional 18 shares during the last quarter. Finally, Huntington National Bank lifted its position in Mettler-Toledo International by 20.0% during the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier’s stock worth $81,000 after acquiring an additional 9 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Price Performance

MTD opened at $1,335.76 on Friday. Mettler-Toledo International Inc. has a 1-year low of $1,133.46 and a 1-year high of $1,546.93. The stock has a market cap of $28.18 billion, a P/E ratio of 36.01, a P/E/G ratio of 4.19 and a beta of 1.12. The stock’s 50 day simple moving average is $1,245.04 and its 200 day simple moving average is $1,343.30.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $10.21 earnings per share for the quarter, beating the consensus estimate of $10.00 by $0.21. The company had revenue of $954.54 million for the quarter, compared to analyst estimates of $941.93 million. Mettler-Toledo International had a negative return on equity of 531.78% and a net margin of 21.15%. Research analysts expect that Mettler-Toledo International Inc. will post 40.42 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts have recently commented on MTD shares. Wells Fargo & Company cut their price target on Mettler-Toledo International from $1,400.00 to $1,350.00 and set an “equal weight” rating for the company in a research note on Monday, November 11th. Citigroup upgraded shares of Mettler-Toledo International from a “sell” rating to a “neutral” rating and upped their price objective for the stock from $1,200.00 to $1,300.00 in a research report on Wednesday, December 11th. Evercore ISI raised shares of Mettler-Toledo International from an “in-line” rating to an “outperform” rating and lifted their target price for the company from $1,375.00 to $1,450.00 in a report on Thursday, January 2nd. Stifel Nicolaus cut their price target on shares of Mettler-Toledo International from $1,550.00 to $1,450.00 and set a “buy” rating for the company in a report on Monday, November 11th. Finally, Wolfe Research initiated coverage on Mettler-Toledo International in a report on Friday, December 13th. They issued a “peer perform” rating on the stock. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $1,351.25.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider Gerry Keller sold 140 shares of the firm’s stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $1,254.09, for a total transaction of $175,572.60. Following the completion of the transaction, the insider now owns 6 shares of the company’s stock, valued at approximately $7,524.54. This trade represents a 95.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Elisha W. Finney sold 76 shares of the company’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $1,311.75, for a total value of $99,693.00. Following the completion of the sale, the director now owns 240 shares in the company, valued at $314,820. This represents a 24.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is currently owned by company insiders.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.